Boston Scientific resumes Farapulse pulsed field ablation study in first-line afib

Late last month, Boston Scientific announced it was pausing a study examining pulsed field ablation as a first-line therapy. Now, it has resumed its work to see whether its Farapulse platform can ... Read More

Boston Scientific resumes enrolment in pulsed field ablation trial - Yahoo Finance

Boston Scientific resumes enrolment in pulsed field ablation trial The AVANT GUARD trial investigates the safety and efficacy of pulsed field ablation (PFA) as a first-line treatment for ... Read More

Second phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpoints - NEWS10 ABC

Trial achieves positive results in the treatment of persistent atrial fibrillation MARLBOROUGH, Mass. and SAN DIEGO, April 24, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today ... Read More

FDA greenlights add-ons for Boston Scientific’s Farapulse field ablation system - MSN

Boston Scientific has launched its Farawave NAV ablation catheter and Faraview software after the US Food and Drug Administration (FDA) approved the two devices. The technologies are used in ... Read More

Boston Sci stock falls 4% amid FARAPULSE study update

Boston Scientific (NYSE:BSX) shares were down 5% in morning trading Wednesday following news that the company has paused a study for its new FARAPULSE Pulse Field Ablation system due to unforeseen ... Read More

Boston Scientific Launches Next Generation of Cardiac Mapping for the FARAPULSE™ Pulsed Field Ablation System | | news-journal.com

New FARAWAVE™ NAV Ablation Catheter and FARAVIEW™ Software combine with OPAL HDx™ Mapping System to provide visualization during pulsed field ablation MARLBOROUGH, Mass., Oct. 18, 2024 ... Read More

Boston Scientific Receives Japanese Regulatory Approval for the FARAPULSE™ Pulsed Field Ablation System | | news-journal.com

MARLBOROUGH, Mass., Sept. 27, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced it has received Pharmaceuticals and Medical Device Agency (PMDA) approval in Japan for the ... Read More

Abbott advances two pulsed field ablation studies for AFib treatment - MSN

Abbott has reached two milestones in a pair of trials evaluating the company’s pulsed field ablation (PFA) technology for the treatment of abnormal heart rhythms. The first milestone came in the ... Read More

Boston Scientific resumes enrolment in pulsed field ablation trial - Yahoo Finance

Boston Scientific has resumed enrolment for its AVANT GUARD clinical trial, after it was paused in October 2024to “assess a few unanticipated observations”. The trial – which tests Boston ... Read More

Second phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpoints - KELOLAND.com

Trial achieves positive results in the treatment of persistent atrial fibrillation MARLBOROUGH, Mass. and SAN DIEGO, April 24, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today ... Read More

Boston Scientific Launches Next Generation of Cardiac Mapping for the FARAPULSE™ Pulsed Field Ablation System

New FARAWAVE™ NAV Ablation Catheter and FARAVIEW™ Software combine with OPAL HDx™ Mapping System to provide visualization during pulsed field ablation MARLBOROUGH, Mass., Oct. 18, 2024 ... Read More

Second phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpoints - WATE 6 On Your Side

Trial achieves positive results in the treatment of persistent atrial fibrillation MARLBOROUGH, Mass. and SAN DIEGO, April 24, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today ... Read More